BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33851711)

  • 1. Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria.
    Park HJ; Montgomery JR; Boggs NA
    Mil Med; 2022 Dec; 187(9):e1556-e1558. PubMed ID: 33851711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allergy to Pfizer-BioNTech® vaccine demonstrated by skin testing].
    Estrada-García CD; Macías-Robles AP; Cortés-Grimaldo RM; Carvajal-Alonso HL; Barreto-Alcalá M; Ramírez-Nepomuceno A; Esparza-Amaya D; Coronado-Hernández KG; Barrios-Díaz B; Campos-Téllez HH
    Rev Alerg Mex; 2023 Jan; 69(2):89-92. PubMed ID: 36928249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory chronic spontaneous urticaria after heterologous COVID-19 booster vaccination.
    Tomaras MC; Douglas LM; Schmidt RM; Bloomquist MS; Diwan AH; Kim SJ
    Dermatol Online J; 2024 Apr; 30(2):. PubMed ID: 38959931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines.
    Shavit R; Maoz-Segal R; Offengenden I; Yahia SH; Maayan DM; Lifshitz Y; Niznik S; Deutch M; Elbaz E; Genaim H; Iancovici-Kidon M; Agmon-Levin N
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2677-2684. PubMed ID: 35973526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.
    Hurst M; Jordan A; Capstick J; Brewerton M; Cockroft R; Ingram J
    Intern Med J; 2022 Oct; 52(10):1818-1820. PubMed ID: 36000384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
    PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
    Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database.
    Falotico JM; Desai AD; Shah A; Ricardo JW; Lipner SR
    Am J Clin Dermatol; 2022 Sep; 23(5):729-737. PubMed ID: 35931925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19.
    Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID
    Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
    Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination.
    Beatty AL; Peyser ND; Butcher XE; Cocohoba JM; Lin F; Olgin JE; Pletcher MJ; Marcus GM
    JAMA Netw Open; 2021 Dec; 4(12):e2140364. PubMed ID: 34935921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    Abi Zeid Daou C; Natout MA; El Hadi N
    J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic.
    Lyons D; Murray C; Hannigan S; Sui J; Alamin S; Conlon N; Keogan M; Khalib K; Fitzpatrick C; O'B Hourihane J; Carey M; Edgar JDM
    Clin Exp Immunol; 2022 Aug; 209(2):182-187. PubMed ID: 35753019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.
    Brockow K; Mathes S; Fischer J; Volc S; Darsow U; Eberlein B; Biedermann T
    Allergy; 2022 Jul; 77(7):2200-2210. PubMed ID: 34806775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience.
    Arroliga ME; Dhanani K; Arroliga AC; Huddleston PS; Trahan J; Aguilar T; Weldon D
    Allergy Asthma Proc; 2021 Sep; 42(5):395-399. PubMed ID: 34474708
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose.
    AlMuhizi F; Ton-Leclerc S; Fein M; Tsoukas C; Garvey LH; Lee D; Ben-Shoshan M; Isabwe GAC; Copaescu AM
    Front Allergy; 2022; 3():825164. PubMed ID: 35386647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suspected Anaphylactic Reaction Following Second Dose of the Pfizer-BioNTech (BNT162b2) Coronavirus Vaccine in a Geriatric Female.
    Hong A; Sardinas G
    HCA Healthc J Med; 2022; 3(6):349-354. PubMed ID: 37427315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.